ETON — Eton Pharmaceuticals Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates ETON Bullish with a Setup Score of 51, net conviction 62, actionability 42. How the Setup Score works →

Total Setup Score51
Directional BiasBullish
Net Conviction62
Actionability42 (in range)

Key signals behind this score

About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhy… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$55.21
Market Cap$1.56B
Float22.3M
Shares Outstanding28.6M
P/E (Forward)23.92
P/E (TTM)136.88
Price/Sales (TTM)14.82
vs. Analyst Target+28.6% to analyst PT
Profit Margin12.02%
Operating Margin (TTM)35.77%
Revenue (TTM)$106M
Earnings Growth (YoY)-12.60%
Dividend RateNone
Analyst Target Price$71.00 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $39,000 -$28.0M -$247,000 -$26.5M
2021 $21.8M -$2.0M $19.2M -$1.5M
2022 $21.3M -$9.0M $14.3M -$7.2M
2023 $31.6M -$936,000 $21.1M $212,000
2024 $39.0M -$3.8M $23.4M -$657,000
2025 $80.0M -$4.6M $42.7M $4.3M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $22.5M -$1.9M
Dec 2025 $21.3M $1.5M
Mar 2026 $24.3M $1.6M
Jun 2026 $37.6M $11.6M

Ownership & Float

Insider Ownership4.9%
Institutional Ownership71.1%
Short Float6.0%
% of All Funds Holding1.88%
Number of Funds Holding165

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$56.60Near-term / short-term trend
Weekly40-Week SMA$34.01Medium-term trend
Weekly80-Week SMA$25.32Cyclical trend (business cycle)
Weekly200-Week SMA$13.60Secular trend (multi-year)
Monthly10-Month SMA$36.10Near-term monthly trend
Monthly20-Month SMA$26.41Medium-term monthly trend
Monthly40-Month SMA$16.45Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$47.00 support 1.73x 1 months ago
$37.00 support 1.56x 2 months ago
$28.20 support 1.23x 3 months ago
$24.70 support 1.41x 4 months ago
$17.10 support 1.26x 6 months ago

Historical Earnings Reactions (31 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.77% -0.88% 41.94% 28.46% -11.74%
1 Day 1.47% 0.29% 51.61% 38.08% -15.23%
1 Week 4.24% 5.76% 61.29% 63.85% -41.73%
2 Weeks 4.88% 4.07% 54.84% 87.31% -43.80%
1 Month 5.73% 3.51% 54.84% 100.00% -29.60%

Next earnings: November 5, 2026 (26 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.0%50.0%8
Feb0.8%50.0%8
Mar0.1%50.0%8
Apr4.1%37.5%8
May1.9%62.5%8
Jun-4.4%25.0%8
Jul0.4%50.0%8
Aug17.0%75.0%8
Sep4.5%50.0%8
Oct6.8%57.1%7
Nov5.1%57.1%7
Dec5.2%62.5%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.09% 48.7% 372
Tuesday 0.23% 51.5% 408
Wednesday 0.18% 52.0% 406
Thursday 0.13% 47.5% 398
Friday 0.49% 47.9% 397

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 71.1%

Insider Transactions — Smart Summary

Total insider ownership: 4.9%

12-Month Insider Activity Summary

Total Filings9
Net Value-$14.6M
Net Shares Change-368,350
% of Float-1.7%
C-Suite Filings5
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
BRYNJELSEN SEAN President & CEO -$9.9M 2 2 sell
Opaleye Management Inc. -$5.8M 2 2 sell
Krempa David Chief Business Officer -$4.7M 3 3 sell
MAIER PAUL V -$2.7M 1 1 sell
Adams Jennifer McKie -$1.4M 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-08-20 – 2026-08-31 3 3 -$10.2M 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-10-06 Krempa David Chief Business Officer -$229,406.206 Transaction at $55.07, now +0.3%
2026-08-20 BRYNJELSEN SEAN President & CEO -$6.1M Transaction at $60.88, now -9.3%
2026-08-31 MAIER PAUL V -$2.7M Transaction at $31.78, now +73.7%
2026-08-24 Krempa David Chief Business Officer -$1.4M Transaction at $36.19, now +52.6%
2026-07-17 Opaleye Management Inc. -$1.1M Transaction at $37.54, now +47.1%
2026-05-29 BRYNJELSEN SEAN President & CEO -$3.8M Transaction at $31.88, now +73.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Eton Pharmaceuticals Inc (ETON) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ETON on Trend Edge →